Standout Papers

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL... 2008 2026 2014 2020 572
  1. Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease (2008)
    Norihiro Nishimoto, Kimio Terao et al. Blood

Immediate Impact

28 by Nobel laureates 39 from Science/Nature 93 standout
Sub-graph 1 of 20

Citing Papers

Targeting IL-6 trans-signalling: past, present and future prospects
2023 Standout
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy
2021 Standout
45 intermediate papers

Works of Toru Mima being referenced

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease
2008 Standout
Interleukin 6 plays a key role in the development of antigen-induced arthritis
1998
and 5 more

Author Peers

Author Last Decade Papers Cites
Toru Mima 921 315 662 752 50 2.4k
Yoshitaka Morita 764 185 649 993 103 2.7k
Koji Kinoshita 792 334 584 1052 87 2.1k
Frans A. Prins 367 296 979 1000 60 3.2k
María Galindo-Izquierdo 871 118 506 833 111 2.5k
C Nagant de Deuxchaisnes 791 154 445 312 78 2.3k
Yuefang Huang 540 269 1187 936 54 2.4k
P. C. Limburg 1253 268 529 1249 52 3.6k
Chul‐Soo Cho 824 75 733 659 70 2.3k
Gurtej S. Cheema 1319 169 343 1176 26 2.8k
Peter T. Chapman 1227 929 506 471 82 3.1k

All Works

Loading papers...

Rankless by CCL
2026